Send to a Friend Share

Biopure (BPUR) Hires Newbury Piret & Co. to Help Explore Strategic Options

February 17, 2009 3:07 PM EST
Biopure Corporation (Nasdaq: BPUR) is exploring strategic options for financing or alternative transactions. The company has engaged Newbury Piret & Co. to advise on options, including evaluation of nonbinding proposals that have been received. There should be no assumption that this process will result in any transaction or any particular type of transaction.

On February 13, 2009, the company filed with the SEC its Annual Report on Form 10-K, which contains the company's financial statements for the two years ended October 31, 2008. The company does not intend to issue a separate earnings release. The report of the company's independent registered public accounting firm contained in this filing is modified with respect to the company's ability to continue as a going concern.

Biopure Corporation develops pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body's tissues. [SM]

You May Also Be Interested In


Related Categories

Corporate News, Trader Talk

Add Your Comment





Follow StreetInsider.com On Twitter